Assembly Biosciences, Inc. SEC filings ASMB

Assembly Biosciences, Inc. has 901 filings in SEC EDGAR's recent list, going back to Feb 7, 2008. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.

Assembly Biosciences, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 20, 2026 —
8-K/A Amended current report
Results of operations
Aug 14, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Acquisition or sale of assets
Aug 13, 2026 Aug 13, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2026 Jun 4, 2026
8-K Current report
Material agreement, Other events
May 26, 2026 May 21, 2026
424B5 Prospectus supplement May 26, 2026 —
424B5 Prospectus supplement May 22, 2026 —
8-K Current report
Regulation FD disclosure, Other events
May 22, 2026 May 22, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 4, 2026
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Mar 30, 2026 Mar 24, 2026
EFFECT Filing Mar 27, 2026 —
CORRESP Letter to the SEC Mar 25, 2026 —
UPLOAD Letter from the SEC Mar 24, 2026 —
S-3 Shelf registration Mar 19, 2026 —
S-8 Employee stock plan registration Mar 19, 2026 —
10-K Annual report Mar 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 19, 2026 Mar 19, 2026
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2025 Dec 8, 2025
EFFECT Filing Nov 21, 2025 —
424B3 Prospectus Nov 21, 2025 —
CORRESP Letter to the SEC Nov 19, 2025 —
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
S-3 Shelf registration Oct 14, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 11, 2025 Aug 8, 2025
424B5 Prospectus supplement Aug 11, 2025 —
424B5 Prospectus supplement Aug 11, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Aug 8, 2025 Aug 8, 2025
S-3MEF Filing Aug 7, 2025 —
S-8 Employee stock plan registration Aug 6, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations, Other events
Aug 6, 2025 Aug 6, 2025
8-K Current report
Other events
Jun 25, 2025 Jun 25, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 9, 2025 Jun 5, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 5, 2025
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
EFFECT Filing Apr 1, 2025 —
CORRESP Letter to the SEC Mar 28, 2025 —
UPLOAD Letter from the SEC Mar 26, 2025 —
S-3 Shelf registration Mar 20, 2025 —
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
8-K Current report
Other events
Feb 20, 2025 Feb 20, 2025
8-K Current report
Material agreement, New debt
Jan 3, 2025 Dec 30, 2024
8-K Current report
Other events
Dec 26, 2024 Dec 26, 2024
8-K Current report
Material agreement, Unregistered share sale
Dec 19, 2024 Dec 19, 2024
8-K Current report
Bylaw or fiscal year change
Dec 13, 2024 Dec 12, 2024
8-K Current report
Material agreement
Nov 7, 2024 Nov 7, 2024
424B5 Prospectus supplement Nov 7, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Other events
Sep 23, 2024 Sep 23, 2024
S-8 Employee stock plan registration Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Material agreement, Unregistered share sale
Jun 18, 2024 Jun 16, 2024
424B5 Prospectus supplement Jun 18, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 3, 2024 May 29, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
DEFA14A Additional proxy material Apr 17, 2024 —
DEF 14A Proxy statement Apr 17, 2024 May 29, 2024
ARS Annual report to shareholders Apr 17, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
8-K Current report
Officer or director change
Mar 15, 2024 Mar 12, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Feb 13, 2024 Feb 8, 2024
8-K Current report
Shareholder vote results, Other events
Feb 2, 2024 Jan 31, 2024
8-K Current report
Agreement ended
Jan 17, 2024 Jan 11, 2024
DEFA14A Additional proxy material Dec 21, 2023 —
DEF 14A Proxy statement Dec 21, 2023 Jan 31, 2024
PRE 14A Preliminary proxy statement Dec 11, 2023 Jan 31, 2024
8-K Current report
Officer or director change, Other events
Dec 7, 2023 Dec 1, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Material agreement, Unregistered share sale
Oct 17, 2023 Oct 15, 2023
8-K Current report
Listing notice
Sep 29, 2023 Sep 27, 2023
S-8 Employee stock plan registration Aug 9, 2023 —
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Material agreement, New debt
Aug 7, 2023 Aug 4, 2023
8-K Current report
Officer or director change, Shareholder vote results
May 30, 2023 May 25, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
8-K Current report
Other events
Apr 18, 2023 Apr 18, 2023
EFFECT Filing Apr 14, 2023 —
CORRESP Letter to the SEC Apr 12, 2023 —
DEFA14A Additional proxy material Apr 12, 2023 —
DEF 14A Proxy statement Apr 12, 2023 May 25, 2023
ARS Annual report to shareholders Apr 12, 2023 Dec 31, 2022
PRE 14A Preliminary proxy statement Mar 31, 2023 May 25, 2023
UPLOAD Letter from the SEC Mar 24, 2023 —
S-3 Shelf registration Mar 22, 2023 —
10-K Annual report Mar 22, 2023 Dec 31, 2022
8-K Current report
Results of operations, Other events
Mar 22, 2023 Mar 22, 2023
8-K Current report
Other events
Feb 15, 2023 Feb 15, 2023
8-K Current report
Other events
Dec 19, 2022 Dec 19, 2022
8-K Current report
Officer or director change, Bylaw or fiscal year change
Dec 12, 2022 Dec 6, 2022
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 5, 2022 Oct 5, 2022
S-8 Employee stock plan registration Aug 9, 2022 —
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Jul 20, 2022 Jul 19, 2022
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
May 27, 2022 May 25, 2022
8-K Current report
Other events
May 24, 2022 May 18, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
DEFA14A Additional proxy material Apr 12, 2022 —
DEF 14A Proxy statement Apr 12, 2022 May 25, 2022
PRE 14A Preliminary proxy statement Apr 1, 2022 May 25, 2022
10-K Annual report Mar 11, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 10, 2022 Mar 10, 2022
8-K Current report
Officer or director change
Feb 4, 2022 Feb 1, 2022
8-K Current report
Other events
Jan 4, 2022 Jan 4, 2022
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Other events
Sep 1, 2021 Sep 1, 2021
S-8 Employee stock plan registration Aug 5, 2021 —
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Officer or director change
Aug 3, 2021 Jul 30, 2021
8-K Current report
Officer or director change
Jul 20, 2021 Jul 19, 2021
8-K Current report
Officer or director change
Jun 1, 2021 May 25, 2021
8-K Current report
Officer or director change, Shareholder vote results
May 25, 2021 May 20, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
DEFA14A Additional proxy material Apr 7, 2021 —
DEF 14A Proxy statement Apr 7, 2021 May 20, 2021
8-K Current report
Other events
Feb 26, 2021 Feb 26, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations, Other events
Feb 25, 2021 Feb 25, 2021
8-K Current report
Officer or director change
Feb 17, 2021 Feb 11, 2021
UPLOAD Letter from the SEC Feb 11, 2021 —
8-K Current report
Bylaw or fiscal year change, Other events
Jan 27, 2021 Jan 21, 2021
CORRESP Letter to the SEC Jan 12, 2021 —
UPLOAD Letter from the SEC Dec 29, 2020 —
8-K Current report
Exit or restructuring costs, Officer or director change
Dec 8, 2020 Dec 2, 2020
8-K Current report
Other events
Nov 17, 2020 Nov 16, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations, Other events
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change
Oct 21, 2020 Oct 19, 2020
EFFECT Filing Sep 4, 2020 —
CORRESP Letter to the SEC Sep 3, 2020 —
UPLOAD Letter from the SEC Sep 2, 2020 —
S-8 Employee stock plan registration Aug 28, 2020 —
S-3 Shelf registration Aug 28, 2020 —
8-K Current report
Other events
Aug 27, 2020 Aug 27, 2020
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020
8-K Current report
Material agreement, Other events
Jul 20, 2020 Jul 17, 2020
8-K Current report
Agreement ended
Jun 18, 2020 Jun 12, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 16, 2020 Jun 11, 2020
DEFA14A Additional proxy material May 19, 2020 —
10-Q Quarterly report May 8, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 27, 2020 —
DEF 14A Proxy statement Apr 27, 2020 Jun 11, 2020
PRE 14A Preliminary proxy statement Apr 16, 2020 Jun 11, 2020
10-K Annual report Mar 4, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 4, 2020 Mar 4, 2020
SEC STAFF LETTER Filing Feb 26, 2020 —
8-K Current report
Officer or director change
Feb 11, 2020 Feb 6, 2020
SEC STAFF LETTER Filing Feb 11, 2020 —
8-K Current report
Other events
Jan 3, 2020 Jan 1, 2020
8-K Current report
Material agreement
Dec 16, 2019 Dec 11, 2019
424B5 Prospectus supplement Dec 13, 2019 —
424B5 Prospectus supplement Dec 11, 2019 —
8-K Current report
Other events
Nov 12, 2019 Nov 11, 2019
S-8 Employee stock plan registration Nov 7, 2019 —
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 7, 2019 Nov 7, 2019
8-K Current report
Officer or director change
Oct 28, 2019 Oct 28, 2019
8-K Current report
Officer or director change, Bylaw or fiscal year change
Aug 9, 2019 Aug 6, 2019
S-8 Employee stock plan registration Aug 5, 2019 —
10-Q Quarterly report Aug 5, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 5, 2019 Aug 5, 2019
8-K Current report
Officer or director change, Shareholder vote results
May 21, 2019 May 17, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
8-K Current report
Officer or director change
May 2, 2019 Apr 30, 2019
8-K Current report
Officer or director change
Apr 22, 2019 Apr 17, 2019
DEFA14A Additional proxy material Apr 4, 2019 —
DEF 14A Proxy statement Apr 4, 2019 May 17, 2019
10-K Annual report Feb 28, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 28, 2019 Feb 28, 2019
10-Q Quarterly report Nov 8, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 8, 2018 Nov 8, 2018
8-K Current report
Officer or director change
Oct 12, 2018 Oct 10, 2018
S-8 Employee stock plan registration Aug 8, 2018 —
10-Q Quarterly report Aug 8, 2018 Jun 30, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ASMB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1426800
Former names
VENTRUS BIOSCIENCES INC (until Jul 11, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.